16.69
Neogenomics Inc (NEO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
8.03%
201.66
|
186.67 | 190.17 | 187.80 | 181.33 |
| Cost Of Revenue |
3.75%
109.78
|
105.81 | 106.83 | 107.35 | 104.07 |
| Gross Profit |
13.62%
91.88
|
80.86 | 83.34 | 80.45 | 77.26 |
| Operating Expenses |
2.57%
101.65
|
99.11 | 96.76 | 107.46 | 124.89 |
| Operating Income/Loss |
46.43%
-9.771
|
-18.24 | -13.41 | -27.01 | -47.63 |
| Income/Loss From Continuing Operations Before Tax |
110.39%
1.826
|
-17.58 | -12.41 | -26.39 | -45.82 |
| Income Tax Expense/Benefit |
12.71%
-0.412
|
-0.472 | -2.525 | 0.74 | -0.724 |
| Net Income/Loss |
113.08%
2.238
|
-17.11 | -9.881 | -27.13 | -45.09 |
| Basic Average Shares |
0.36%
129.63
|
129.17 | 0.184 | 128.41 | 127.95 |
| Diluted Average Shares |
1.29%
130.83
|
129.17 | 0.184 | 128.41 | 127.95 |
大文字化:
|
ボリューム (24 時間):